JPH05507475A - ロイコトリエン関連疾患治療用安息香酸誘導体 - Google Patents

ロイコトリエン関連疾患治療用安息香酸誘導体

Info

Publication number
JPH05507475A
JPH05507475A JP91509448A JP50944891A JPH05507475A JP H05507475 A JPH05507475 A JP H05507475A JP 91509448 A JP91509448 A JP 91509448A JP 50944891 A JP50944891 A JP 50944891A JP H05507475 A JPH05507475 A JP H05507475A
Authority
JP
Japan
Prior art keywords
aliphatic group
compound according
group
aryl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP91509448A
Other languages
English (en)
Japanese (ja)
Inventor
デイニーズ，ロバート・エイ
キングスベリー，ウイリアム・デニス
ペンドラク，イスライル
Original Assignee
スミスクライン・ビーチャム・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スミスクライン・ビーチャム・コーポレイション filed Critical スミスクライン・ビーチャム・コーポレイション
Publication of JPH05507475A publication Critical patent/JPH05507475A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP91509448A 1990-06-07 1991-05-15 ロイコトリエン関連疾患治療用安息香酸誘導体 Pending JPH05507475A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53438890A 1990-06-07 1990-06-07
US534.388 1990-06-07
PCT/US1991/003399 WO1991018880A1 (fr) 1990-06-07 1991-05-15 Derives d'acide benzoique utilises dans le traitement de maladies associees au leucotriene

Publications (1)

Publication Number Publication Date
JPH05507475A true JPH05507475A (ja) 1993-10-28

Family

ID=24129833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP91509448A Pending JPH05507475A (ja) 1990-06-07 1991-05-15 ロイコトリエン関連疾患治療用安息香酸誘導体

Country Status (16)

Country Link
EP (1) EP0532550A1 (fr)
JP (1) JPH05507475A (fr)
KR (1) KR930700445A (fr)
CN (1) CN1058016A (fr)
AU (1) AU7901791A (fr)
CA (1) CA2083958A1 (fr)
FI (1) FI925544A (fr)
HU (1) HUT64748A (fr)
IE (2) IE911912A1 (fr)
IL (1) IL98388A0 (fr)
MA (1) MA22196A1 (fr)
MX (1) MX26142A (fr)
PL (1) PL290586A1 (fr)
PT (1) PT97912A (fr)
WO (1) WO1991018880A1 (fr)
ZA (1) ZA914323B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022285A1 (fr) * 1992-05-01 1993-11-11 Smithkline Beecham Corporation Antagonistes de leucotrienes
WO1995015950A1 (fr) * 1993-12-08 1995-06-15 Smithkline Beecham Corporation Composes
MA22926A1 (fr) * 1992-06-30 1994-04-01 Smithkline Beecham Corp Procede pour la preparation de nouveaux composes.
JPH08505148A (ja) * 1992-12-23 1996-06-04 スミスクライン・ビーチャム・コーポレイション ロイコトリエンアンタゴニストとして有用な置換ピリジル化合物
WO1995028386A1 (fr) * 1994-04-13 1995-10-26 F. Hoffmann-La Roche Ag Antagonistes des leucotrienes b4 a substitution pyridine
US7297357B2 (en) * 2001-03-27 2007-11-20 Meiji Seika Kaisha, Ltd. Process for producing puffed snack and production apparatus therefor
EP3192872A1 (fr) 2003-08-26 2017-07-19 The Regents of the University of Colorado, a body corporate Inhibiteurs de l'activité de sérine protéase et leur utilisation dans les procédés et compositions pour le traitement des infections bactériennes
US8093253B2 (en) 2008-03-06 2012-01-10 Hoffmann-La Roche Inc. Leukotriene B4 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4563446A (en) * 1983-07-27 1986-01-07 Takeda Chemical Industries, Ltd. Thromboxane synthetase inhibiting 3-(1-alkenyl) pyridines
GB8505285D0 (en) * 1985-03-01 1985-04-03 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
IE911912A1 (en) 1991-12-18
CA2083958A1 (fr) 1991-12-08
HUT64748A (en) 1994-02-28
KR930700445A (ko) 1993-03-15
PL290586A1 (en) 1992-04-06
AU7901791A (en) 1991-12-31
MA22196A1 (fr) 1992-04-01
EP0532550A1 (fr) 1993-03-24
IL98388A0 (en) 1992-07-15
ZA914323B (en) 1992-06-24
MX26142A (es) 1994-02-28
HU9203866D0 (en) 1993-03-29
FI925544A0 (fi) 1992-12-07
CN1058016A (zh) 1992-01-22
PT97912A (pt) 1992-03-31
IE911913A1 (en) 1991-12-18
WO1991018880A1 (fr) 1991-12-12
FI925544A (fi) 1992-12-07

Similar Documents

Publication Publication Date Title
DE602004006631T2 (de) Matrix metalloprotease inhibitoren
DE60215699T2 (de) Quinolinone als prostaglandin rezeptor liganden
DE69732966T2 (de) Substituierte indazolderivate und ihre verwendung als inhibitoren des phosphodiesterase (pde) des typs iv und der produktion des tumor nekrosis faktors (tnf)
DE69926542T2 (de) Aminopyrazolderivate
US4038396A (en) Anti-inflammatory oxazole[4,5-b]pyridines
DE69118388T2 (de) Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
DE60201859T2 (de) Pharmazeutische Verwendung von N-Carbamoylazol-Derivate
EA017530B1 (ru) Производные 1-фенил-2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстераз
JP2002522541A (ja) ホスホジエステラーゼ４阻害剤としての置換１，８−ナフチリジン−４（１ｈ）−オン
JP2007524682A (ja) 代謝調節型グルタミン酸受容体−５の調節物質としてのビピリジルアミド
JPH05507713A (ja) 置換ベンズイミダゾール、その製造方法およびその薬学的使用
DE69709493T2 (de) Substituierte Indazolderivate
JPH11505236A (ja) フェニルジヒドロベンゾフラン
DE3522579C2 (de) Neue 1,4-Dihydropyridin-Derivate und Salze derselben, Verfahren zur Herstellung derselben und pharmazeutische Mittel mit einem Gehalt derselben
JPH05507475A (ja) ロイコトリエン関連疾患治療用安息香酸誘導体
JPH01301661A (ja) 新規ピリジル誘導体
DE60024648T2 (de) Carbonsäuren und acylsulfonamide, diese verbindungen enthaltende zubereitungen und behandlungsmethoden
JPH06510786A (ja) ロイコトリエン関連疾患治療用ピリジン化合物
JPH05507492A (ja) 安息香酸誘導体
ES2391371T3 (es) Derivados de la 2-trifluorometilnicotinamida como agentes para aumentar el HDL-colesterol
JPH03163074A (ja) フラン誘導体
JPH05507701A (ja) ロイコトリエン関連疾患治療用フタルアミド酸およびその異性体
FR2911605A1 (fr) Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique
WO1998058930A1 (fr) Composes de triazolo-1,4-diazepine et composition medicinale les contenant
US4783473A (en) Geminally substituted cyclic ether carboxylic acids, derivatives thereof, compositions containing same and method of use